Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Document re: Charlemagne Capital

9 Dec 2016 10:55

RNS Number : 4555R
Charlemagne Capital Limited
09 December 2016
Β 

PUBLICΒ DEALINGΒ DISCLOSUREΒ BYΒ AΒ PARTYΒ TOΒ ANΒ OFFERΒ ORΒ PERSONΒ ACTINGΒ INΒ 

CONCERTΒ (INCLUDINGΒ DEALINGSΒ FORΒ THEΒ ACCOUNTΒ OFΒ DISCRETIONARYΒ INVESTMENTΒ CLIENTS)

Β 

Charlemagne Capital isΒ a CaymanΒ IslandsΒ company andΒ isΒ not subject to theΒ UK CityΒ CodeΒ onΒ TakeoversΒ and MergersΒ (the "Code"). AccordinglyΒ theΒ CodeΒ doesΒ notΒ apply to the OfferΒ byΒ Fiera CapitalΒ for Charlemagne Capital and thisΒ transactionΒ isΒ notΒ subject to theΒ jurisdiction of, orΒ being regulatedΒ by,Β the UK Panel on TakeoversΒ and MergersΒ (the "Takeover Panel"). However, Charlemagne Capital andΒ Fiera Capital haveΒ agreed, to the extentΒ set outΒ inΒ the Implementation Agreement, that theyΒ willΒ conductΒ themselvesΒ and the Offer asΒ ifΒ the Offer were subjectΒ to the Code.

Β 

DisclosuresΒ made in relation to relevant securitiesΒ of Charlemagne CapitalΒ shouldΒ be releasedΒ viaΒ aΒ Regulatory Information Service using the headline "Document re: Charlemagne Capital". The headlineΒ "FormΒ 8/8.3"shouldΒ notΒ be used.Β AnyΒ question regardingΒ completion of theseΒ forms should be raisedΒ with N+1Β SingerΒ (tel: +44Β (0) 20 7496 3000). Charlemagne Capital ShareholdersΒ and personsΒ consideringΒ theΒ acquisition orΒ disposal ofΒ anyΒ interest in Charlemagne Capital SharesΒ are remindedΒ thatΒ theyΒ areΒ subjectΒ to the Disclosure and TransparencyΒ Rules made byΒ the UKLAΒ andΒ otherΒ applicableΒ regulatoryΒ rulesΒ regardingΒ transactionsΒ in CharlemagneΒ Capital Shares.

Β 

1. KEYΒ INFORMATION

Β 

(a) Full name of discloser:

Β Mary Catherine Spinks

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Β 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Charlemagne Capital Limited

(d) Status of person making the disclosure:

e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree)

Shareholder of Charlemagne Capital Limited

(e) Date dealing undertaken:

08-December-2016

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

If YES, specify which:

Β 

2. POSITIONSΒ OFΒ THEΒ PERSONΒ MAKINGΒ THEΒ DISCLOSURE

Β 

IfΒ thereΒ areΒ positionsΒ orΒ rightsΒ toΒ subscribeΒ toΒ discloseΒ inΒ moreΒ thanΒ oneΒ classΒ ofΒ relevantΒ securitiesΒ ofΒ theΒ offerorΒ orΒ offereeΒ namedΒ inΒ 1(c),Β copyΒ tableΒ 2(a)Β orΒ (b)Β (asΒ appropriate)Β forΒ eachΒ additionalΒ classΒ ofΒ relevantΒ security.

Β 

(a) InterestsΒ andΒ shortΒ positionsΒ inΒ theΒ relevantΒ securitiesΒ ofΒ theΒ offerorΒ orΒ offereeΒ toΒ whichΒ theΒ disclosureΒ relatesΒ followingΒ theΒ dealing

Β 

Class of relevant security:

Ordinary Shares

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

4,663,438*

3,663,438**

1.6*

1.3**

Β 

Β 

(2) Cash-settled derivatives:

Β 

Β 

Β 

Β 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Β 

Β 

Β 

Β 

Β 

Total

4,663,438*

3,663,438**

Β 

Β 

1.6*

1.3**Β 

Β 

Β 

Β 

*Before sale described in part 3 below

**After sale described in part 3 below

AllΒ interestsΒ andΒ allΒ shortΒ positionsΒ shouldΒ beΒ disclosed.

Β 

DetailsΒ ofΒ anyΒ openΒ stock-settledΒ derivativeΒ positionsΒ (includingΒ tradedΒ options),Β orΒ agreementsΒ toΒ purchaseΒ orΒ sellΒ relevantΒ securities,Β shouldΒ beΒ givenΒ onΒ aΒ SupplementalΒ FormΒ (OpenΒ Positions).

Β 

DetailsΒ ofΒ anyΒ securitiesΒ borrowingΒ andΒ lendingΒ positionsΒ orΒ financialΒ collateralΒ arrangementsΒ shouldΒ beΒ disclosedΒ onΒ aΒ SupplementalΒ FormΒ (SBL).

Β 

(b) RightsΒ toΒ subscribeΒ forΒ newΒ securitiesΒ (includingΒ directors'Β andΒ otherΒ employeeΒ options)

Β 

Class of relevant security in relation to which subscription right exists:

NA

Details, including nature of the rights concerned and relevant percentages:

NA

Β 

3. DEALINGSΒ BYΒ THEΒ PERSONΒ MAKINGΒ THEΒ DISCLOSURE

Β 

WhereΒ thereΒ haveΒ beenΒ dealingsΒ inΒ moreΒ than oneΒ classΒ ofΒ relevantΒ securitiesΒ ofΒ theΒ offerorΒ orΒ offereeΒ namedΒ inΒ 1(c),Β copyΒ tableΒ 3(a),Β (b), (c) or (d)Β (asΒ appropriate) for eachΒ additionalΒ classΒ ofΒ relevantΒ securityΒ dealtΒ in.

Β 

TheΒ currencyΒ ofΒ allΒ pricesΒ andΒ otherΒ monetaryΒ amountsΒ shouldΒ beΒ stated.

Β 

(a) PurchasesΒ andΒ sales

Β 

(i) PartyΒ toΒ anΒ offerΒ orΒ personΒ actingΒ inΒ concertΒ (except forΒ aΒ principalΒ traderΒ inΒ theΒ sameΒ groupΒ asΒ aΒ connectedΒ adviser)

Β 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

Ordinary Shares

Sale

1,000,000

13.75

Β 

(ii) PrincipalΒ traderΒ whereΒ theΒ soleΒ reasonΒ forΒ theΒ connectionΒ isΒ thatΒ theΒ principalΒ traderΒ isΒ inΒ theΒ sameΒ groupΒ asΒ aΒ connectedΒ adviser

Β 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Β 

Β 

Β 

Β 

Β 

Β 

(b) Cash-settledΒ derivativeΒ transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a

long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

Β 

Β 

Β 

(c) Stock-settledΒ derivativeΒ transactionsΒ (includingΒ options)

(i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Class of relevan t securit y

Product descriptio n e.g. call option

Writing, purchasing

, selling, varying etc.

Number of securitie s to which option relates

Exercis e price per unit

Type

e.g.

American

,

Europea n etc.

Expir y date

Option money paid/ receive d per unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

Β 

Β 

Β 

(d) OtherΒ dealingsΒ (includingΒ subscribingΒ forΒ newΒ securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

Β 

Β 

4. OTHERΒ INFORMATION

Β 

(a) IndemnityΒ andΒ otherΒ dealingΒ arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

NONE

Β 

Β 

(b) Agreements,Β arrangementsΒ orΒ understandingsΒ relatingΒ toΒ optionsΒ orΒ derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

Β 

Β 

(c) Attachments

Β 

AreΒ anyΒ SupplementalΒ FormsΒ attached? No

Β 

Supplemental Form (Open Positions)

NO

Supplemental Form (SBL)

NO

Β 

Β 

Date of disclosure:

08-December-2016

Contact name:

Mary Catherine Spinks

Telephone number:

+1 432 686 0720

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DOCUKSRRNWAURAA
Date   Source Headline
14th Jan 20147:00 amRNSTrading Statement
11th Oct 20133:28 pmRNSQ3 2013 AUM Update
17th Sep 20139:52 amRNSDividend Declaration
17th Sep 20137:00 amRNSHalf Yearly Report
10th Sep 20134:59 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
22nd Aug 20136:08 pmRNSNotification of Significant Shareholding
12th Jul 20137:00 amRNSInterim Management Statement
8th Jul 20136:03 pmRNSNotification of Significant Shareholding
25th Jun 201310:14 amRNSChange in Significant Interest
20th Jun 201312:02 pmRNSChange in Significant Shareholding
13th Jun 201312:40 pmRNSResult of AGM
20th May 20134:49 pmRNSAnnual Report and Notice of AGM
26th Mar 20139:00 amRNSDividend Declaration
26th Mar 20137:00 amRNSFinal Results
6th Feb 20134:40 pmRNSSecond Price Monitoring Extn
6th Feb 20134:35 pmRNSPrice Monitoring Extension
23rd Jan 20134:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20134:35 pmRNSPrice Monitoring Extension
22nd Jan 20137:00 amRNSAppointment of Sole Broker
21st Jan 20139:34 amRNSNotification of Major Interest in Shares
5th Nov 20127:00 amRNSAdviser Change of Name
11th Oct 201210:15 amRNSSignificant Shareholding Announcement
10th Oct 20129:46 amRNSQ3 2012 AUM Update (Replacement)
10th Oct 20127:00 amRNSQ3 2012 AUM Update
18th Sep 20127:00 amRNSResults for the six months to 30 June 2012
11th Jul 20127:00 amRNSInterim Management Statement
27th Jun 201211:14 amRNSDirector Declaration
14th Jun 20123:21 pmRNSAGM Statement
10th May 20129:58 amRNSNotice of AGM
4th May 20122:00 pmRNSDirector/PDMR Shareholding
27th Apr 201212:58 pmRNSEuropean Convergence Development Company PLC
5th Apr 20124:04 pmRNSDirector/PDMR Shareholding
5th Apr 20127:00 amRNSAUM update
29th Mar 20125:59 pmRNSDirectors Dealings
29th Mar 20127:00 amRNSDirector/PDMR Shareholding
20th Mar 20128:15 amRNSDividend Declaration
20th Mar 20127:00 amRNSFinal Results
12th Jan 20127:00 amRNSTrading Statement
7th Oct 20117:00 amRNSAssets under Management
30th Sep 201112:41 pmRNSNotification of Major Interest in Shares
23rd Sep 20113:46 pmRNSSignificant Shareholding
24th Aug 20117:00 amRNSSignificant Shareholding
5th Aug 20114:40 pmRNSSecond Price Monitoring Extn
5th Aug 20114:35 pmRNSPrice Monitoring Extension
7th Jul 20117:00 amRNSTrading Statement
5th Jul 201111:54 amRNSChange to Significant Shareholding
10th Jun 20117:00 amRNSBusiness Update Announcement
25th May 20114:40 pmRNSSecond Price Monitoring Extn
25th May 20114:35 pmRNSPrice Monitoring Extension
13th May 201112:36 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.